Key result
Nrf2, cooperating with Pdcd4, promoted the infiltration of M1 macrophages and the release of proinflammatory cytokines Il1b and Il6 by initiating the transcription of Ccl3 in early myocardial ischemia-reperfusion.
Why the study?
Nuclear factor erythroid 2 like 2 (Nrf2) reportedly plays an important role in myocardial ischemia-reperfusion injury, but the underlying mechanism remains obscure.
Nrf2 promotes early myocardial ischemia-reperfusion injury by remodeling the immune microenvironment and recruiting Ccr1-positive macrophages via Ccl3.
May exacerbate early IRI via macrophage recruitment in rodents; hypothesis-generating for Nrf2-Ccl3 targeting in human reperfusion injury.
Cardiomyocyte apoptosis in response to inflammation is a primary cause of myocardial ischemia-reperfusion injury (IRI). Nuclear factor erythroid 2 like 2 (Nrf2) reportedly plays an important role in myocardial IRI, but the underlying mechanism remains obscure. Expression data from the normal heart tissues of mice or heart tissues treated with reperfusion for 6 h after ischemia (IR6h) were acquired from the GEO database; changes in biological function and infiltrating immune cells were analyzed. The binding between the molecules was verified by chromatin immunoprecipitation sequencing. Based on confirmation that early myocardial ischemia-reperfusion (myocardial ischemia/reperfusion for 6 hours, IR6h) promoted myocardial apoptosis and inflammatory response, we found that Nrf2, cooperating with Programmed Cell Death 4, promoted transcription initiation of C-C Motif Chemokine Ligand 3 (Ccl3) in myocardial tissues of mice treated with IR6h. Moreover, Ccl3 contributed to the high signature score of C-C motif chemokine receptor 1 (Ccr1)-positive macrophages. The high signature score of Ccr1-positive macrophages leads to the release of pro-inflammatory factors interleukin 1 beta and interleukin 6. This study is the first to elucidate the damaging effect of Nrf2 via remodeling of the immune microenvironment in early myocardial ischemia-reperfusion, which provides us with new perspectives and treatment strategies for myocardial ischemia-reperfusion.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied Myocardial ischemia-reperfusion injury (n=18). Myocardial ischemia-reperfusion vs. Sham operation was evaluated on Infiltration of M1 macrophages and release of proinflammatory cytokines. Nrf2, cooperating with Pdcd4, promoted the infiltration of M1 macrophages and the release of proinflammatory cytokines Il1b and Il6 by initiating the transcription of Ccl3 in early myocardial ischemia-reperfusion.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: